Treatment Centers & Clinical Trials

Finding the best amyloidosis care is not easy. ARC created My Amyloidosis Pathfinder (MAP) to help you discover, learn about, and contact treatment centers and clinical trials that are right for you. By answering our short questionnaire, MAP is able to match you to centers and trials specific to your condition.


Finding a Treatment Center

Finding the right treatment center is a crucial part of your care. MAP only shows you treatment centers with the capability to provide excellent treatment for your type of amyloidosis. We provide extensive information on each center, allowing you to make an informed decision.

What are Clinical Trials

Clinical trials are research studies that are designed to explore whether a medical strategy, drug treatment, or device is safe and effective for patients. Studies can also look at other aspects of care, such as improving quality of life for patients.

Why Clinical Trials are Important

Clinical trials allow researchers to test the safety and effectiveness of new, promising drugs. Before any drug can be approved, it must be rigorously tested in clinical trials. Without the participation of patients, new treatments and cures will never happen. In addition, participating in a clinical trial may be a great way for patients to access new treatments before they become available. Especially in a rare disease such as amyloidosis, clinical trials can be a vital resource for your care.

Finding a Clinical Trial

MAP also matches you to clinical trials for which you may be eligible. In amyloidosis, clinical trials can be a great way to access promising new treatments. Clinical trials are a critical step in the development of much needed drugs for amyloidosis patients. Especially in a rare disease, these important trials are often significantly delayed due to lack of participants. This can seriously slow down the rate at which new drugs are discovered, tested, and made available to patients.

320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170

ARC is a 501(c)(3) nonprofit organization. Tax ID: 47-2589708
©2024 ARC – Amyloidosis Research Consortium, Inc. All rights reserved.

Guidestar Platinum Transparency 2023 2021 Top Rated Great Non Profits Charity Navigator Four-Star Rating